share_log

T2 Biosystems | SC 13G: Statement of acquisition of beneficial ownership by individuals-JACOB SAFIER(5.7%),JSAF HOLDINGS, LLC(5.7%)

T2 Biosystems | SC 13G: Statement of acquisition of beneficial ownership by individuals-JACOB SAFIER(5.7%),JSAF HOLDINGS, LLC(5.7%)

T2 Biosystems | SC 13G:超過5%持股股東披露文件-JACOB SAFIER(5.7%),JSAF HOLDINGS, LLC(5.7%)
美股SEC公告 ·  2024/11/07 10:07

Moomoo AI 已提取核心訊息

On October 30, 2024, a significant filing was made with the United States Securities and Exchange Commission by JSAF Holdings, LLC and Jacob Safier, indicating a substantial investment in T2 Biosystems, Inc. The Schedule 13G filing, dated November 6, 2024, reveals that JSAF Holdings and Jacob Safier collectively own 1,000,000 shares of T2 Biosystems' common stock, which represents 5.7% of the company's class of securities. This level of ownership classifies them as major shareholders, as they possess both sole voting and dispositive power over the shares. The filing asserts that the acquisition of these shares is not intended for the purpose of changing or influencing the control of T2 Biosystems, nor is it connected with any transaction that has such a purpose or effect. The principal business address for both JSAF Holdings and Jacob Safier is listed as The Wolfson Group, located in New York, NY.
On October 30, 2024, a significant filing was made with the United States Securities and Exchange Commission by JSAF Holdings, LLC and Jacob Safier, indicating a substantial investment in T2 Biosystems, Inc. The Schedule 13G filing, dated November 6, 2024, reveals that JSAF Holdings and Jacob Safier collectively own 1,000,000 shares of T2 Biosystems' common stock, which represents 5.7% of the company's class of securities. This level of ownership classifies them as major shareholders, as they possess both sole voting and dispositive power over the shares. The filing asserts that the acquisition of these shares is not intended for the purpose of changing or influencing the control of T2 Biosystems, nor is it connected with any transaction that has such a purpose or effect. The principal business address for both JSAF Holdings and Jacob Safier is listed as The Wolfson Group, located in New York, NY.
2024年10月30日,JSAF Holdings,LLC和Jacob Safier向美國證券交易委員會提交了一項重要的申報,表明他們對t2 biosystems公司進行了大筆投資。日期爲2024年11月6日的13G表格顯示,JSAF Holdings和Jacob Safier共擁有t2 biosystems公司普通股100萬股,佔該公司證券類別的5.7%。這一所有權水平將其分類爲主要股東,因爲他們對這些股份擁有獨立的投票和決定權。申報指出,這些股份的收購併非意在改變或影響t2 biosystems公司的控制權,也與具有此目的或效果的任何交易無關。JSAF Holdings和Jacob Safier的主要業務地址均列爲紐約市的The Wolfson Group。
2024年10月30日,JSAF Holdings,LLC和Jacob Safier向美國證券交易委員會提交了一項重要的申報,表明他們對t2 biosystems公司進行了大筆投資。日期爲2024年11月6日的13G表格顯示,JSAF Holdings和Jacob Safier共擁有t2 biosystems公司普通股100萬股,佔該公司證券類別的5.7%。這一所有權水平將其分類爲主要股東,因爲他們對這些股份擁有獨立的投票和決定權。申報指出,這些股份的收購併非意在改變或影響t2 biosystems公司的控制權,也與具有此目的或效果的任何交易無關。JSAF Holdings和Jacob Safier的主要業務地址均列爲紐約市的The Wolfson Group。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息